semaglutide phase 3 In an interim analysis of a trial involving 800 patients with metabolic dysfunction–associated steatohepatitis, once-weekly improved liver histologic results at 72 weeks. Full ESSENCE trial results and Research Summary Oral Semaglutide Lowers HbA1c in

C nhiu nm trong lnh vc dc phm

Landmark trials include STEP (semaglutide for weight management, NEJM 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)

It's not in the market yet but is expected to be soon...patiently waiting to see how it compares to the cost of other newly launched generics (especially as a GLP-1 RA)

Chief among those concerns are side effects, with 51% of respondents citing current side effects such as nausea, vomiting, headaches, and more as a top concern when it comes to GLP-1 medications, while 40% said they are worried about potential long-term side effects that may develop with use

A critical area for research is the extent of the anticancer effects and apoptosis induction by curcumin